Literature DB >> 3218450

Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function.

E Bäckman1, E Nylander, I Johansson, K G Henriksson, C Tagesson.   

Abstract

16 boys with Duchenne muscular dystrophy (DMD) were treated with sodium selenite and vitamin E for one year. One group of patients (10 boys) was examined using a battery of tests to assess muscular strength and function and cardiopulmonary function, and by CT scanning of 2 muscle groups over the 4 years prior to treatment. Six boys with DMD entered the study when the treatment was begun. Tests of muscular force and function, cardiopulmonary tests and CT-scanning were performed at the onset of treatment, and after 6 and 12 months. No beneficial effect on either muscular force or function was found during the treatment period. It is concluded that selenium and vitamin E in high doses do not improve muscle function in DMD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3218450     DOI: 10.1111/j.1600-0404.1988.tb03681.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

Review 1.  Physiological and nutritional importance of selenium.

Authors:  J Nève
Journal:  Experientia       Date:  1991-02-15

Review 2.  Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.

Authors:  Luis Garegnani; Martin Hyland; Pablo Roson Rodriguez; Camila Micaela E Escobar Liquitay; Juan Va Franco
Journal:  Cochrane Database Syst Rev       Date:  2021-11-08

Review 3.  Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.

Authors:  Luis Garegnani; Martin Hyland; Pablo Roson Rodriguez; Camila Micaela Escobar Liquitay; Juan Va Franco
Journal:  Cochrane Database Syst Rev       Date:  2021-12-01

Review 4.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

Review 5.  Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.

Authors:  Yan Burelle; Maya Khairallah; Alexis Ascah; Bruce G Allen; Christian F Deschepper; Basil J Petrof; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

Review 6.  Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

Authors:  David G Allen; Nicholas P Whitehead; Stanley C Froehner
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.